268 related articles for article (PubMed ID: 15319299)
1. Nicotine promotes gastric tumor growth and neovascularization by activating extracellular signal-regulated kinase and cyclooxygenase-2.
Shin VY; Wu WK; Ye YN; So WH; Koo MW; Liu ES; Luo JC; Cho CH
Carcinogenesis; 2004 Dec; 25(12):2487-95. PubMed ID: 15319299
[TBL] [Abstract][Full Text] [Related]
2. n-3 PUFAs reduce VEGF expression in human colon cancer cells modulating the COX-2/PGE2 induced ERK-1 and -2 and HIF-1alpha induction pathway.
Calviello G; Di Nicuolo F; Gragnoli S; Piccioni E; Serini S; Maggiano N; Tringali G; Navarra P; Ranelletti FO; Palozza P
Carcinogenesis; 2004 Dec; 25(12):2303-10. PubMed ID: 15358633
[TBL] [Abstract][Full Text] [Related]
3. Nicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induce cyclooxygenase-2 activity in human gastric cancer cells: Involvement of nicotinic acetylcholine receptor (nAChR) and beta-adrenergic receptor signaling pathways.
Shin VY; Jin HC; Ng EK; Yu J; Leung WK; Cho CH; Sung JJ
Toxicol Appl Pharmacol; 2008 Dec; 233(2):254-61. PubMed ID: 18805435
[TBL] [Abstract][Full Text] [Related]
4. Nicotine induces cyclooxygenase-2 and vascular endothelial growth factor receptor-2 in association with tumor-associated invasion and angiogenesis in gastric cancer.
Shin VY; Wu WK; Chu KM; Wong HP; Lam EK; Tai EK; Koo MW; Cho CH
Mol Cancer Res; 2005 Nov; 3(11):607-15. PubMed ID: 16317086
[TBL] [Abstract][Full Text] [Related]
5. Functional role of beta-adrenergic receptors in the mitogenic action of nicotine on gastric cancer cells.
Shin VY; Wu WK; Chu KM; Koo MW; Wong HP; Lam EK; Tai EK; Cho CH
Toxicol Sci; 2007 Mar; 96(1):21-9. PubMed ID: 17003101
[TBL] [Abstract][Full Text] [Related]
6. Helicobacter pylori VacA toxin up-regulates vascular endothelial growth factor expression in MKN 28 gastric cells through an epidermal growth factor receptor-, cyclooxygenase-2-dependent mechanism.
Caputo R; Tuccillo C; Manzo BA; Zarrilli R; Tortora G; Blanco Cdel V; Ricci V; Ciardiello F; Romano M
Clin Cancer Res; 2003 Jun; 9(6):2015-21. PubMed ID: 12796363
[TBL] [Abstract][Full Text] [Related]
7. Nicotine promotes colon tumor growth and angiogenesis through beta-adrenergic activation.
Wong HP; Yu L; Lam EK; Tai EK; Wu WK; Cho CH
Toxicol Sci; 2007 Jun; 97(2):279-87. PubMed ID: 17369603
[TBL] [Abstract][Full Text] [Related]
8. Signal transduction cascade in staurosporine-induced prostaglandin E(2) production by rat peritoneal macrophages.
Yamaki K; Yonezawa T; Ohuchi K
J Pharmacol Exp Ther; 2000 Apr; 293(1):206-13. PubMed ID: 10734171
[TBL] [Abstract][Full Text] [Related]
9. Cyclooxygenase-2 increases hypoxia-inducible factor-1 and vascular endothelial growth factor to promote angiogenesis in gastric carcinoma.
Huang SP; Wu MS; Shun CT; Wang HP; Hsieh CY; Kuo ML; Lin JT
J Biomed Sci; 2005; 12(1):229-41. PubMed ID: 15864753
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated receptor-gamma-independent mechanism.
Grau R; Iñiguez MA; Fresno M
Cancer Res; 2004 Aug; 64(15):5162-71. PubMed ID: 15289320
[TBL] [Abstract][Full Text] [Related]
11. The MEK/ERK pathway mediates COX-2-selective NSAID-induced apoptosis and induced COX-2 protein expression in colorectal carcinoma cells.
Elder DJ; Halton DE; Playle LC; Paraskeva C
Int J Cancer; 2002 May; 99(3):323-7. PubMed ID: 11992399
[TBL] [Abstract][Full Text] [Related]
12. Combination of a selective cyclooxygenase-2 inhibitor with epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 and protein kinase A antisense causes cooperative antitumor and antiangiogenic effect.
Tortora G; Caputo R; Damiano V; Melisi D; Bianco R; Fontanini G; Veneziani BM; De Placido S; Bianco AR; Ciardiello F
Clin Cancer Res; 2003 Apr; 9(4):1566-72. PubMed ID: 12684433
[TBL] [Abstract][Full Text] [Related]
13. KRC-408, a novel c-Met inhibitor, suppresses cell proliferation and angiogenesis of gastric cancer.
Hong SW; Jung KH; Park BH; Zheng HM; Lee HS; Choi MJ; Yun JI; Kang NS; Lee J; Hong SS
Cancer Lett; 2013 May; 332(1):74-82. PubMed ID: 23348694
[TBL] [Abstract][Full Text] [Related]
14. Celecoxib inhibits phorbol ester-induced expression of COX-2 and activation of AP-1 and p38 MAP kinase in mouse skin.
Chun KS; Kim SH; Song YS; Surh YJ
Carcinogenesis; 2004 May; 25(5):713-22. PubMed ID: 14729583
[TBL] [Abstract][Full Text] [Related]
15. Cyclooxygenase-2-regulated vascular endothelial growth factor release in gastric fibroblasts.
Miura S; Tatsuguchi A; Wada K; Takeyama H; Shinji Y; Hiratsuka T; Futagami S; Miyake K; Gudis K; Mizokami Y; Matsuoka T; Sakamoto C
Am J Physiol Gastrointest Liver Physiol; 2004 Aug; 287(2):G444-51. PubMed ID: 15246970
[TBL] [Abstract][Full Text] [Related]
16. Correlation of MAP kinases with COX-2 induction differs between MKN45 and HT29 cells.
Tominaga K; Higuchi K; Sasaki E; Suto R; Watanabe T; Fujiwara Y; Oshitani N; Matsumoto T; Kim S; Iwao H; Arakawa T
Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 1():143-50. PubMed ID: 15298620
[TBL] [Abstract][Full Text] [Related]
17. Growth stimulation of COX-2-negative pancreatic cancer by a selective COX-2 inhibitor.
Eibl G; Takata Y; Boros LG; Liu J; Okada Y; Reber HA; Hines OJ
Cancer Res; 2005 Feb; 65(3):982-90. PubMed ID: 15705899
[TBL] [Abstract][Full Text] [Related]
18. Salicylate regulates COX-2 expression through ERK and subsequent NF-kappaB activation in osteoblasts.
Chae HJ; Chae SW; Reed JC; Kim HR
Immunopharmacol Immunotoxicol; 2004 Feb; 26(1):75-91. PubMed ID: 15106733
[TBL] [Abstract][Full Text] [Related]
19. A mechanistic study of cigarette smoke and cyclooxygenase-2 on proliferation of gastric cancer cells.
Shin VY; Liu ES; Ye YN; Koo MW; Chu KM; Cho CH
Toxicol Appl Pharmacol; 2004 Feb; 195(1):103-12. PubMed ID: 14962510
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of cyclooxygenase-2 and tumor angiogenesis in human gastric cancer.
Koga T; Shibahara K; Kabashima A; Sumiyoshi Y; Kimura Y; Takahashi I; Kakeji Y; Maehara Y
Hepatogastroenterology; 2004; 51(60):1626-30. PubMed ID: 15532792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
